Atlas Venture Advisors, Inc. Long-Term Concentrated

Location: Boston, MA

CIK: 0001767432 · Show all filings

Period: Q1 2020 (← Previous) (Next →)

Filing Date: May 7, 2020

Total Value: $73.86M (100.0% shares, 0.0% debt)

Holdings (7)

— TRANSLATE BIO INC 52.9%

Value $39.1M Shares 3,922,008 Est. Cost $7.50 Unrealized —

BCYC BICYCLE THERAPEUTICS PLC 25.2%

Value $18.6M Shares 1,362,696 Est. Cost $10.06 Unrealized —

ROKU ROKU INC 6.8%

Value $5.048M Shares 57,707 Est. Cost $137.43 Unrealized -16.2%

DDOG DATADOG INC 5.5%

Value $4.074M Shares 113,232 Est. Cost $34.77 Unrealized +18.5%

SNAP SNAP INC 4.0%

Value $2.92M Shares 245,559 Est. Cost $6.50 Unrealized +136.0%

— ZAFGEN INC 3.7%

Value $2.7M Shares 3,506,207 Est. Cost $4.95 Unrealized —

— MIRAGEN THERAPEUTICS INC 1.9%

Value $1.414M Shares 3,142,580 Est. Cost $3.03 Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
—	TRANSLATE BIO INC	3,922,008	$39.1M	52.9%	$7.50	—	COM	89374L104
BCYC	BICYCLE THERAPEUTICS PLC	1,362,696	$18.6M	25.2%	$10.06	—	SPONSORED ADS	088786108
ROKU	ROKU INC	57,707	$5.048M	6.8%	$137.43	-16.2%	COM CL A	77543R102
DDOG	DATADOG INC	113,232	$4.074M	5.5%	$34.77	+18.5%	CL A COM	23804L103
SNAP	SNAP INC	245,559	$2.92M	4.0%	$6.50	+136.0%	CL A	83304A106
—	ZAFGEN INC	3,506,207	$2.7M	3.7%	$4.95	—	COM	98885E103
—	MIRAGEN THERAPEUTICS INC	3,142,580	$1.414M	1.9%	$3.03	—	COM	60463E103